Department of Clinical Neuroscience
At the Department of Clinical Neuroscience (CNS), we conduct research and teaching regarding the function of the brain - from a molecular level to the effect on society.
KI Lifestyle4Health: Best Paper Award for junior researchers
KI Lifestyle4Health: Best Paper Award for junior researchers
Apply or nominate candidates for the “Best paper award 2022” for junior researchers at KI! This award is aimed to reward scientists in early stages of their career for outstanding work. The application deadline is July 15th 2022
Staffan Holmin is awarded the Prize for Innovation and Utilization, 2022
Staffan Holmin is awarded the Prize for Innovation and Utilization, 2022
Staffan Holmin at the Department of Clinical Neuroscience at Karolinska Institutet, is awarded the Prize for Innovation and Utilization, 2022. The prize recognizes one or more researchers/research students who have distinguished themselves through outstanding utilization of research results that have led to innovation.
Findings open way for personalised MS treatment
Findings open way for personalised MS treatment
Currently available therapies to treat multiple sclerosis (MS) lack precision and can lead to serious side effects. Researchers at KI have now developed a method for identifying the immune cells involved in autoimmune diseases, and have identified four new target molecules of potential significance for future personalised treatment of MS. The results, which are published in Science Advances, have been obtained in collaboration with KTH Royal Institute of Technology and Region Stockholm.
#91: Medicinvetarna - Is addiction a disease?
#91: Medicinvetarna - Is addiction a disease?
Are you addicted or are you just suffering from a bad habit? Researcher Joar Guterstam explains the concepts and no, you can not be sugar, exercise or mobile dependent. However, drugs and gambling for money can lead to an addiction that requires care. And it is more effective than many people know. NB The podcast is in Swedish!
Kristoffer Månsson on the cover of Biological Psychiatry Journal
Kristoffer Månsson on the cover of Biological Psychiatry Journal
The cover art is an illustration of how moment-to-moment brain signal variability differs across individuals. In this issue, Månsson et al. demonstrate that such individual differences in brain signal variability formed a reliable and accurate predictor of treatment success in patients with social anxiety disorder receiving cognitive behavioral therapy.
StratNeuro supports clinical neuroscience research in 2022
StratNeuro supports clinical neuroscience research in 2022
The StratNeuro board has reviewed the neuroscience submissions to the SLL call “Kliniska Forskare” (2020) and decided to support Mikael Tiger with SEK 500,000, for his project entitled "Optimized treatment for depression: mechanisms of action and response markers and antidepressive effect versus side effects".
Johan Lundström´s postcovid research receives funding from The Swedish Research Council
Johan Lundström´s postcovid research receives funding from The Swedish Research Council
The Swedish Research Council grants 14 research projects at KI for their research about postcovid. A total of SEK 50 million is granted, of which SEK 4 300 000 is awarded to Johan Lundström´s research project ”Prevalence and treatments of post-COVID olfactory dysfunction”.
Environment and Sustainable Development at CNS
We as part of a University has a central roll in the work to combat climate change, both by contributing through teaching and research, but we also need to contribute by reducing the impact of our own activities. Here you can find tips on what changes you can do in your daily life to reduce your climate footprint.
GDPR at KI
The General Data Protection Regulation (GDPR, or Dataskyddsförordningen) for the processing of personal data is to be applied on May 25 2018 in Sweden. Here you will find information on GDPR and the implementation of the regulation at KI.